Skip to content

Company · founded 2010

EuBiologics (South Korea)

Chuncheon, South Korea · eubiologics.com/en/main

Manage this page

Citations, last 5 years: 151
Works, last 5 years: 22
h-index: 20
Scientists listed: 4
Grants since 2016: 5

Grants received

2025–2027 · research · Global Health

Eubiologics - to test malaria immunogen sequences and EuBiologics' adjuvant platform for the generation of malaria elimination vaccine candidates for the world's...

EuBiologics (South Korea) · funded by Bill and Melinda Gates Foundation

$1.6MMalaria Research and Control

2023–2024 · research · Global Health

Eubiologics - to maximize the short term supply of oral cholera vaccine for gavi markets.

EuBiologics (South Korea) · funded by Bill and Melinda Gates Foundation

$343.9kVibrio bacteria research studies

2022–2027 · research · Global Health

Eubiologics - to develop a low cost multivalent meningococcal vaccine

EuBiologics (South Korea) · funded by Bill and Melinda Gates Foundation

$3.9MBacterial Infections and Vaccines

2022–2025 · research · Global Health

Eubiologics - to increase the global supply of oral cholera vaccines (OCV) for deployment in endemic settings and for the control of cholera epidemics in develop...

EuBiologics (South Korea) · funded by Bill and Melinda Gates Foundation

$4.2MVibrio bacteria research studies

2019–2024 · research · Global Health

Eubiologics - to increase the global supply of OCV for deployment in endemic settings and for the control of cholera epidemics in developing countries

EuBiologics (South Korea) · funded by Bill and Melinda Gates Foundation

$4.7M